This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

X-Change Corp In Discussions To Rollout Phytiva Products In China And Southeast Asia

DALLAS, Jan. 25, 2013 /PRNewswire/ -- X-Change Corp (NASDAQ OTC: XCHC), a U.S. boutique company whose niche is extract-based cosmeceutical and nutraceutical solutions through its Phytiva brand product line, announced today that it has been in discussions with a couple of OTC-traded companies to rollout some or all of Phytiva products to consumers in China and Southeast Asia.  The powerhouse of China, along with Southeast Asia, which includes the robust, dynamic countries of Vietnam and Thailand, have outlets that have expressed an interest in using nutraceutical-based products to cure everyday diseases, such as migraine headache, back problems, skin care ailments, and depression. Two-thirds of the world's population is heavily concentrated in China and its bordering countries.  A majority of the Asian population relies heavily on home-grown herbal products to cure everyday diseases.  X-Change Corp. has been approached by several US-based cannabis research and development facilities in California with ties to China's and Vietnam's herbal distribution networks. Negotiations are underway to send samples to those countries for patient testing and promotion among local physicians, with a goal of product rollout thereafter.

"We are very pleased to have this one-in-a-lifetime opportunity to dramatically expand our products line to the millions of booming consumers of China and Southeast Asia. With such a huge population and high consumer demand already in place, Phytiva products could play an important role in curing everyday diseases and ailments in these Asian countries. We look forward to these continuing discussions and, hopefully, Phytiva Products will be chosen for testing and then rollout in China, Vietnam, and Thailand in a month or two," stated Robert Kane, President of X-Change Corp.

About Phytiva

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
SYM TRADE IT LAST %CHG

Markets

DOW 18,041.54 -190.48 -1.04%
S&P 500 2,104.20 -21.86 -1.03%
NASDAQ 5,032.7510 -56.6110 -1.11%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs